California State Teachers Retirement System (CalSTRS)
BEAM icon

California State Teachers Retirement System (CalSTRS)’s Beam Therapeutics BEAM Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59M Sell
104,505
-3,236
-3% -$97.7K ﹤0.01% 1274
2026
Q1 		$2.57M Buy
107,741
+20,476
+23% +$568K ﹤0.01% 1380
2025
Q4 		$2.42M Buy
87,265
+4,212
+5% +$107K ﹤0.01% 1313
2025
Q3 		$2.02M Buy
83,053
+20
+0% +$398 ﹤0.01% 1400
2025
Q2 		$1.41M Buy
83,033
+231
+0.3% +$4.02K ﹤0.01% 1554
2025
Q1 		$1.62M Buy
82,802
+16,840
+26% +$441K ﹤0.01% 1452
2024
Q4 		$1.64M Sell
65,962
-698
-1% -$17.8K ﹤0.01% 1503
2024
Q3 		$1.63M Sell
66,660
-1,635
-2% -$42.2K ﹤0.01% 1514
2024
Q2 		$1.6M Sell
68,295
-1,519
-2% -$37.3K ﹤0.01% 1510
2024
Q1 		$2.31M Sell
69,814
-2,066
-3% -$64.4K ﹤0.01% 1322
2023
Q4 		$1.96M Sell
71,880
-757
-1% -$18.8K ﹤0.01% 1449
2023
Q3 		$1.75M Sell
72,637
-1,060
-1% -$28.4K ﹤0.01% 1474
2023
Q2 		$2.35M Buy
73,697
+525
+0.7% +$17K ﹤0.01% 1395
2023
Q1 		$2.24M Sell
73,172
-1,177
-2% -$46.5K ﹤0.01% 1404
2022
Q4 		$2.91M Buy
74,349
+881
+1% +$39.5K ﹤0.01% 1254
2022
Q3 		$3.5M Sell
73,468
-165
-0.2% -$9.41K 0.01% 1109
2022
Q2 		$2.85M Buy
73,633
+22,565
+44% +$897K ﹤0.01% 1285
2022
Q1 		$2.93M Sell
51,068
-4,881
-9% -$320K ﹤0.01% 1376
2021
Q4 		$4.46M Buy
55,949
+3,403
+6% +$291K 0.01% 1223
2021
Q3 		$4.57M Sell
52,546
-12,205
-19% -$1.23M 0.01% 1196
2021
Q2 		$8.33M Buy
64,751
+4,586
+8% +$365K 0.01% 920
2021
Q1 		$4.82M Sell
60,165
-182
-0.3% -$17.3K 0.01% 1217
2020
Q4 		$4.93M Buy
60,347
+6,867
+13% +$338K 0.01% 1118
2020
Q3 		$1.32M Buy
53,480
+34,811
+186% +$864K ﹤0.01% 1728
2020
Q2 		$523K Hold
18,669
– – ﹤0.01% 2221
2020
Q1 		$336K Buy
+18,669
New +$406K ﹤0.01% 2288

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s BEAM Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Beam Therapeutics (BEAM) stake by 3% in Q2 2026, selling an estimated $97.7K and leaving 104,505 shares worth $3.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

California State Teachers Retirement System (CalSTRS) first reported a position in BEAM in Q1 2020 and has held it in 26 quarters since. The position peaked at $8.33M in Q2 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 104,505 shares of Beam Therapeutics worth $3.59M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 3,236 Beam Therapeutics shares in Q2 2026, an estimated $97.7K.
  • Beam Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1274 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Beam Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Beam Therapeutics position peaked at $8.33M in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.